Macrocyclic compounds and methods of use thereof
US-2022143231-A1 · May 12, 2022 · US
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
US12268759B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12268759-B2 |
| Application number | US-202217963823-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 11, 2022 |
| Priority date | Jun 23, 2016 |
| Publication date | Apr 8, 2025 |
| Grant date | Apr 8, 2025 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present technology provides compounds, as well as compositions including such compounds, useful for imaging and/or treatment of a glioma, a breast cancer, an adrenal cortical cancer, a cervical carcinoma, a vulvar carcinoma, an endometrial carcinoma, a primary ovarian carcinoma, a metastatic ovarian carcinoma, a non-small cell lung cancer, a small cell lung cancer, a bladder cancer, a colon cancer, a primary, gastric adenocarcinoma, a primary colorectal adenocarcinoma, a renal cell carcinoma, and/or a prostate cancer.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound that is chelating 177 Lu 3+ .
Assignees
Inventors
Classifications
carboxylic acid carriers, fatty acids (amino acids A61K51/0406) · CPC title
conjugates with a carrier being an organic compounds · CPC title
Antineoplastic agents · CPC title
- A61K51/0482Primary
chelates from cyclic ligands, e.g. DOTA · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12268759B2 cover?
- The present technology provides compounds, as well as compositions including such compounds, useful for imaging and/or treatment of a glioma, a breast cancer, an adrenal cortical cancer, a cervical carcinoma, a vulvar carcinoma, an endometrial carcinoma, a primary ovarian carcinoma, a metastatic ovarian carcinoma, a non-small cell lung cancer, a small cell lung cancer, a bladder cancer, a colon…
- Who is the assignee on this patent?
- Univ Cornell
- What technology area does this patent fall under?
- Primary CPC classification A61K51/0482. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).